Combination therapy with PD-1/PD-L1 blockade: An overview of ongoing clinical trials

Por Johnson, C. Bryce, Win, Shwe Y.
Publicado no Oncoimmunology (2018)

IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness

Por Johnson, C Bryce, May, Bennett R, Cloud, Colleen A, Rubinstein, Mark P, Cole, David J
Publicado em 2013

Closure of VDAC Causes Oxidative Stress and Accelerates the Ca(2+)-induced Mitochondrial Permeability Transition in Rat Liver Mitochondria

Por Tikunov, Andrey, Johnson, C. Bryce, Pediaditakis, Peter, Markevich, Nikolai, Macdonald, Jeffrey M., Lemasters, John J., Holmuhamedov, Ekhson
Publicado em 2010

Synergy of nitric oxide and silver sulfadiazine against Gram-negative, -positive, and antibiotic-resistant pathogens

Por Deupree, Susan M., Privett, Benjamin J., Backlund, Christopher J., Rao, Kavitha S., Johnson, C. Bryce, Coneski, Peter N., Schoenfisch, Mark H.
Publicado em 2010

Bactericidal efficacy of nitric oxide-releasing silica nanoparticles

Por Hetrick, Evan M., Shin, Jae Ho, Stasko, Nathan A., Johnson, C. Bryce, Wespe, Daniel A., Holmuhamedov, Ekhson, Schoenfisch, Mark H.
Publicado em 2008

Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapy

Por Johnson, C. Bryce, Wrangle, John, Mehrotra, Shikhar, Li, Zihai, Paulos, Chrystal M., Cole, David J., Surh, Charles D., Rubinstein, Mark P.
Publicado no Oncoimmunology (2016)

(13)C MRS Detection of Changes in Serine Isotopomers Reflects Changes in Mitochondrial Redox Status

Por Johnson, C. Bryce, Tikunov, Andrey P., Lee, Haakil, Wolak, Justyna E., Pediaditakis, Peter, Romney, Doug A., Holmuhamedov, Ekhson, Gamcsik, Michael P., Macdonald, Jeffrey M.
Publicado em 2011

IL-2 and Beyond in Cancer Immunotherapy

Por Wrangle, John M., Patterson, Alicia, Johnson, C. Bryce, Neitzke, Daniel J., Mehrotra, Shikhar, Denlinger, Chadrick E., Paulos, Chrystal M., Li, Zihai, Cole, David J., Rubinstein, Mark P.
Publicado no J Interferon Cytokine Res (2018)

Ex vivo IL-12-Priming during CD8(+) T Cell Activation Dramatically Improves Adoptive T Cell Transfer Anti-Tumor Efficacy in a Lymphodepleted Host

Por Rubinstein, Mark P, Cloud, Colleen A, Garrett, Tracy E, Moore, Caitlin J, Schwartz, Kristina M, Johnson, C Bryce, Craig, David H, Salem, Mohamed L, Paulos, Chrystal M, Cole, David J
Publicado em 2012

Effector CD8(+) T cell engraftment and anti-tumor immunity in lymphodepleted hosts is IL-7Rα dependent

Por Johnson, C. Bryce, Riesenberg, Brian P., May, Bennett R., Gilreath, Stuart C., Li, Guangfu, Staveley-O’Carroll, Kevin F., Garrett-Mayer, Elizabeth, Mehrotra, Shikhar, Cole, David J., Rubinstein, Mark P.
Publicado no Cancer Immunol Res (2015)

Non-invasive Monitoring of L-2-Oxothiazolidine-4-Carboxylate Metabolism in the Rat Brain by In vivo (13)C Magnetic Resonance Spectroscopy

Por Gamcsik, Michael P., Clark, M. Daniel, Ludeman, Susan M., Springer, James B., D’Alessandro, Michael A., Simpson, Nicholas E., Pourdeyhimi, Roxana, Johnson, C. Bryce, Teeter, Stephanie D., Blackband, Stephen J., Thelwall, Peter E.
Publicado em 2010

Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor α/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma

Por Xu, Wenxin, Jones, Monica, Liu, Bai, Zhu, Xiaoyun, Johnson, C. Bryce, Edwards, Ana C., Kong, Lin, Jeng, Emily K., Han, Kaiping, Marcus, Warren D., Rubinstein, Mark P., Rhode, Peter R., Wong, Hing C.
Publicado em 2013

Enhanced lymphodepletion is insufficient to replace exogenous IL-2 or IL-15 therapy in augmenting the efficacy of adoptively transferred effector CD8(+) T cells

Por Johnson, C. Bryce, May, Bennett R., Riesenberg, Brian P., Suriano, Samantha, Mehrotra, Shikhar, Garrett-Mayer, Elizabeth, Salem, Mohamed L., Jeng, Emily K., Wong, Hing C., Paulos, Chrystal M., Wrangle, John, Cole, David J., Rubinstein, Mark P.
Publicado no Cancer Res (2018)

Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells

Por Rubinstein, Mark P., Su, Ee Wern, Suriano, Samantha, Cloud, Colleen A., Andrijauskaite, Kristina, Kesarwani, Pravin, Schwartz, Kristina M., Williams, Katelyn M., Johnson, C. Bryce, Li, Mingli, Scurti, Gina M., Salem, Mohamed L., Paulos, Chrystal M., Garrett-Mayer, Elizabeth, Mehrotra, Shikhar, Cole, David J.
Publicado no Cancer Immunol Immunother (2015)